Search

everythinglearnresearchcommunity

for

Search:↓

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Some vaccines might rarely cause hair loss, more research is needed.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Plant cell culture is a promising method for creating sustainable and high-quality cosmetic ingredients.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Mange in rabbits is a serious disease that can spread to humans and is treated with medications and supportive care.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The document provides 70 multiple choice questions to improve haematology skills.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.